A unit of MicroPort CardioFlow Medtech (HKG:2160) agreed to purchase the remaining 49% equity stake it does not already own in Shanghai MicroPort CardioAdvent for 170.9 million yuan, a Friday Hong Kong bourse filing said.
Shanghai MicroPort CardioFlow Medtech will buy a 35.27% stake from MicroPort Sinica and 13.73% from Shanghai Zuoqing Enterprise Management Consulting Service Centre.
Upon completion, it will own 100% of the target company, the filing said.
Shanghai MicroPort CardioAdvent is a high-tech medical device firm specializing in left atrial appendage devices.